GlassScriptPhysician profile
Amina Naseem
NPI 1780314310
$3,859.45
in general payments reported to CMS, 2019-2025
13 companies · $1,017 in 2025
The $1,017 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $244 · 2023: $507 · 2024: $2,091 · 2025: $1,017.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,864 · Travel and Lodging: $751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,863.68 |
| Travel and Lodging | $751.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trimed, INC. | $1,571.46 | 2024 | |
| Stryker Corporation | $1,517.97 | 2022-2025 | Augment Injectable, Hoffmann, Variax |
| Integra Lifesciences Corporation | $207.56 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Anika Therapeutics, INC. | $180.20 | 2022-2025 | Hyalofast, Tactoset, Integrity Implant |
| Paratek Pharmaceuticals, INC. | $124.99 | 2025 | Nuzyra |
| Smith+Nephew, INC. | $64.70 | 2022-2024 | Renasys Go V2 Home |
| Kerecis Limited | $51.06 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Medinc of Texas | $34.26 | 2024 | |
| Paragon 28, INC. | $28.47 | 2023 | Gorilla, Activcore Nail |
| Treace Medical Concepts, INC. | $23.97 | 2024 | |
| Depuy Synthes Sales INC. | $23.11 | 2024 | Na |
| Checkpoint Surgical, INC | $17.90 | 2025 | Checkpoint Stimulators |
| Convatec INC. | $13.80 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amina Naseem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.